|
1
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: Defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parkin DM: Global cancer statistics in the
year 2000. Lancet Oncol. 2:533–543. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bruix J and Sherman M; Practice Guidelines
Committee, : American Association for the Study of Liver Diseases:
Management of hepatocellular carcinoma. Hepatology. 42:1208–1236.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Park KW, Park JW, Choi JI, Kim TH, Kim SH,
Park HS, Park HS, Lee WJ, Park SJ, Hong EK and Kim CM: Survival
analysis of 904 patients with hepatocellular carcinoma in a
hepatitis B virus-endemic area. J Gastroenterol Hepatol.
23:467–473. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Llovet JM, Fuster J and Bruix J;
Barcelona-Clínic Liver Cancer Group, : The Barcelona approach:
Diagnosis, staging, and treatment of hepatocellular carcinoma.
Liver Transpl. 10 (Suppl 1):S115–S120. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou W, Li Y, Gou S, Xiong J, Wu H, Wang
C, Yan H and Liu T: miR-744 increases tumorigenicity of pancreatic
cancer by activating Wnt/β-catenin pathway. Oncotarget.
6:37557–37569. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun Y, Bai Y, Zhang F, Wang Y, Guo Y and
Guo L: miR-126 inhibits non-small cell lung cancer cells
proliferation by targeting EGFL7. Biochem Biophys Res Commun.
391:1483–1489. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fang JH, Zhou HC, Zeng C, Yang J, Liu Y,
Huang X, Zhang JP, Guan XY and Zhuang SM: MicroRNA-29b suppresses
tumor angiogenesis, invasion, and metastasis by regulating matrix
metalloproteinase 2 expression. Hepatology. 54:1729–1740. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang R, Zhao N, Li S, Fang JH, Chen MX,
Yang J, Jia WH, Yuan Y and Zhuang SM: MicroRNA-195 suppresses
angiogenesis and metastasis of hepatocellular carcinoma by
inhibiting the expression of VEGF, VAV2, and CDC42. Hepatology.
58:642–653. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Voorhoeve PM, le Sage C, Schrier M, Gillis
AJ, Stoop H, Nagel R, Liu YP, van Duijse J, Drost J, Griekspoor A,
et al: A genetic screen implicates miRNA-372 and miRNA-373 as
oncogenes in testicular germ cell tumors. Adv Exp Med Biol.
604:17–46. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jing SY, Jing SQ, Liu LL, Xu LF, Zhang F
and Gao JL: Down-expression of miR-373 predicts poor prognosis of
glioma and could be a potential therapeutic target. Eur Rev Med
Pharmacol Sci. 21:2421–2425. 2017.PubMed/NCBI
|
|
15
|
Zhang Q, Wang C, Miao S, Li C, Chen Z and
Li F: Enhancing E-cadherin expression via promoter-targeted miR-373
suppresses bladder cancer cells growth and metastasis. Oncotarget.
8:93969–93983. 2017.PubMed/NCBI
|
|
16
|
Ding W, Fan XL, Xu X, Huang JZ, Xu SH,
Geng Q, Li R, Chen D and Yan GR: Epigenetic silencing of ITGA2 by
miR-373 promotes cell migration in breast cancer. PLoS One.
10:e01351282015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Martins-Filho SN, Paiva C, Azevedo RS and
Alves VAF: Histological grading of hepatocellular carcinoma - a
systematic review of literature. Front Med (Lausanne). 4:1932017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou D, Li Z and Bai X: BRAFV600E and
RET/PTC promote proliferation and migration of papillary thyroid
carcinoma cells in vitro by regulating nuclear factor-κB. Med Sci
Monit. 23:5321–5329. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu H, Zhang Q, Li K, Gong Z, Liu Z, Xu Y,
Swaney MH, Xiao K and Chen Y: Prognostic significance of USP33 in
advanced colorectal cancer patients: New insights into
β-arrestin-dependent ERK signaling. Oncotarget. 7:81223–81240.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Carter P: Site-directed mutagenesis.
Biochem J. 237:1–7. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu H, Xu Y, Zhang Q, Li K, Wang D, Li S,
Ning S, Yang H, Shi W, Liu Z and Chen Y: Correlations between
TBL1XR1 and recurrence of colorectal cancer. Sci Rep. 7:442752017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu H, Liu Z, Li K, Li S, Song L, Gong Z,
Shi W, Yang H, Xu Y, Ning S, et al: TBL1XR1 predicts isolated tumor
cells and micrometastasis in patients with TNM stage I/II
colorectal cancer. J Gastroenterol Hepatol. 32:1570–1580. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Y, Zhao FJ, Chen LL, Wang LQ, Nephew
KP, Wu YL and Zhang S: miR-373 targeting of the Rab22a oncogene
suppresses tumor invasion and metastasis in ovarian cancer.
Oncotarget. 5:12291–12301. 2014.PubMed/NCBI
|
|
25
|
Wei F, Cao C, Xu X and Wang J: Diverse
functions of miR-373 in cancer. J Transl Med. 13:1622015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Baranwal S and Alahari SK: miRNA control
of tumor cell invasion and metastasis. Int J Cancer. 126:1283–1290.
2010.PubMed/NCBI
|
|
27
|
Keklikoglou I, Koerner C, Schmidt C, Zhang
JD, Heckmann D, Shavinskaya A, Allgayer H, Gückel B, Fehm T,
Schneeweiss A, et al: MicroRNA-520/373 family functions as a tumor
suppressor in estrogen receptor negative breast cancer by targeting
NF-κB and TGF-β signaling pathways. Oncogene. 31:4150–4163. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen Y, Luo J, Tian R, Sun H and Zou S:
miR-373 negatively regulates methyl-CpG-binding domain protein 2
(MBD2) in hilar cholangiocarcinoma. Dig Dis Sci. 56:1693–1701.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang LQ, Zhang Y, Yan H, Liu KJ and Zhang
S: MicroRNA-373 functions as an oncogene and targets YOD1 gene in
cervical cancer. Biochem Biophys Res Commun. 459:515–520. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen D, Dang BL, Huang JZ, Chen M, Wu D,
Xu ML, Li R and Yan GR: miR-373 drives the
epithelial-to-mesenchymal transition and metastasis via the
miR-373-TXNIP-HIF1alpha-TWIST signaling axis in breast cancer.
Oncotarget. 6:32701–32712. 2015.PubMed/NCBI
|
|
31
|
Lu S, Zhu Q, Zhang Y, Song W, Wilson MJ
and Liu P: Dual-functions of miR-373 and miR-520c by differently
regulating the activities of MMP2 and MMP9. J Cell Physiol.
230:1862–1870. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu N, Liu X, Xu X, Fan X, Liu M, Li X,
Zhong Q and Tang H: MicroRNA-373, a new regulator of protein
phosphatase 6, functions as an oncogene in hepatocellular
carcinoma. FEBS J. 278:2044–2054. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jang JS, Jeon HS, Sun Z, Aubry MC, Tang H,
Park CH, Rakhshan F, Schultz DA, Kolbert CP, Lupu R, et al:
Increased miR-708 expression in NSCLC and its association with poor
survival in lung adenocarcinoma from never smokers. Clin Cancer
Res. 18:3658–3667. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu X, Liu T, Fang O, Dong W, Zhang F,
Leach L, Hu X and Luo Z: MicroRNA-708-5p acts as a therapeutic
agent against metastatic lung cancer. Oncotarget. 7:2417–2432.
2016.PubMed/NCBI
|
|
35
|
Varnholt H, Drebber U, Schulze F,
Wedemeyer I, Schirmacher P, Dienes HP and Odenthal M: MicroRNA gene
expression profile of hepatitis C virus-associated hepatocellular
carcinoma. Hepatology. 47:1223–1232. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Guo H, Liu H, Mitchelson K, Rao H, Luo M,
Xie L, Sun Y, Zhang L, Lu Y, Liu R, et al: MicroRNAs-372/373
promote the expression of hepatitis B virus through the targeting
of nuclear factor I/B. Hepatology. 54:808–819. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mukherjee A, Di Bisceglie AM and Ray RB:
Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs
the JAK/STAT signaling pathway. J Virol. 89:3356–3365. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cairo S, Wang Y, de Reyniès A, Duroure K,
Dahan J, Redon MJ, Fabre M, McClelland M, Wang XW, Croce CM and
Buendia MA: Stem cell-like micro-RNA signature driven by Myc in
aggressive liver cancer. Proc Natl Acad Sci USA. 107:20471–20476.
2010. View Article : Google Scholar : PubMed/NCBI
|
